TELA Bio - TELA Company Value to Revenue Ratio

The enterprise value-to-revenue ratio allows for an assessment of market expectations for TELA Bio, Inc. (TELA), whose revenue is based on the sale of innovative OviTex grafts. TELA Bio, Inc. (TELA) is expanding its presence in plastic surgery by offering biocompatible implants as an alternative to synthetics. Stable demand and demographics protect performance metrics from macroeconomic shocks, with the indicator settling at 857.12, excluding the impact of debt.
TELA (telabio.com): analytical breakdowns and indicator data

This indicator measures the enterprise value of the business, accounting for net debt per unit of revenue, allowing for an assessment of the asset's real price regardless of capital structure. By analyzing the EV/Sales ratio, an investor can gauge valuation sensitivity to growth rates, which for TELA Bio, Inc. (TELA) reflects the transition from the R&D stage to the commercial scaling of OviTex implants on a stable technological plateau.